NCT05619653 - Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 | Biotech Hunter

Enrollment

279

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions

COVID-19 Associated Cardiac InvolvementRemodeling, Left VentricleRemodeling, VascularLeft Ventricular DysfunctionExercise IntoleranceVascular InflammationMicrovascular Angina

Interventions

DRUG

Prednisolone

randomised double-blind, placebo-controlled clinical trial 1:1 randomisation

DRUG

Losartan

randomised double-blind, placebo-controlled clinical trial 1:1 randomisation

Trial Locations (5)

1090

University Medical Centre Vienna, Vienna

17475

University Hospital Greifswald, Greifswald

24105

University Hospital Schleswig-Holstein, Campus KIEL, Kiel

60596

Institute for experimental and translational cardiovascular imaging, Frankfurt am Main

89081

University Hospital Ulm, Ulm